- Filed
- Aug 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 8, 2024 | 303.18M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $407.81K |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $41.01K |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $1.99M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $1.5M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $6.06M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $4.59M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $440.3K |
| Current Assets | Q2 2024 · Dec 31, 2023 | $76.76K |
| Total Assets | Q2 2024 · Jun 30, 2024 | $1.31M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $1.03M |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 300.24M sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 297.81M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $282.04K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$1.18M |
| Stockholders Equity restated | Q2 2024 · Jun 30, 2023 | −$3.09M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | −$2.35M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$2.36M |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$0.00 |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$0.01 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.01 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $355.32K |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $725.17K |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $762.71K |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $1.45M |
| Net Income restated | Q2 2024 · Jun 30, 2023 | −$1.15M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$2.22M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$1.06M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$1.12M |
| Operating Income restated | Q2 2024 · Jun 30, 2023 | −$2.17M |